Department of Medicine, University of Florida College of Medicine, Gainesville, Florida 32610-0277, USA.
Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14. doi: 10.1016/j.bbmt.2009.09.015. Epub 2009 Sep 23.
Little is known about the health promotion, prevention, and disease screening behaviors of cancer survivors treated with hematopoietic cell transplantation (HCT), who undergo arduous treatment and may be at particular risk for late effects and secondary malignancies. The purposes of this study were to examine the current health and secondary prevention behaviors of long-term HCT survivors compared with matched controls without cancer, and to identify sociodemographic and clinical factors associated with appropriate preventive practices. HCT survivors (n = 662) were drawn from 40 North American transplantation centers. Peer-nominated acquaintances of survivors matched on sex, age, education, and marital status served as controls (n = 158). Data were collected a mean of 6.7 years post-HCT (range, 1.8-22.6 years). Despite a greater frequency of physical exams, the HCT survivors had similar health and screening behaviors as the matched controls. Sociodemographic factors were associated with health prevention behaviors in expected ways. Some differences between disease group and type of transplant were found, with survivors of acute leukemia less likely to report regular exercise, autologous transplant survivors more likely than allogeneic transplant survivors to report screenings for breast and cervical cancer, and allogeneic transplant survivors more likely than autologous transplant survivors to report undergoing a skin exam in the previous year. Despite higher levels of engagement with health care providers, HCT survivors had similar health behaviors as matched controls and comparable to those reported by cancer survivors who did not undergo HCT. There remains considerable room for improvement. These findings support the need for further education of both HCT survivors and health practitioners.
人们对接受造血细胞移植(HCT)治疗的癌症幸存者的健康促进、预防和疾病筛查行为知之甚少,这些患者经历了艰苦的治疗,可能特别容易出现晚期效应和继发性恶性肿瘤。本研究的目的是比较长期 HCT 幸存者与没有癌症的匹配对照者的当前健康和二级预防行为,并确定与适当预防实践相关的社会人口统计学和临床因素。HCT 幸存者(n=662)来自 40 个北美移植中心。幸存者的同龄同龄人、年龄、教育程度和婚姻状况相匹配的同伴提名熟人作为对照(n=158)。数据采集于 HCT 后平均 6.7 年(范围,1.8-22.6 年)。尽管 HCT 幸存者进行体检的频率更高,但他们的健康和筛查行为与匹配对照者相似。社会人口统计学因素以预期的方式与健康预防行为相关。在疾病组和移植类型之间发现了一些差异,急性白血病幸存者不太可能报告定期锻炼,与异基因移植幸存者相比,自体移植幸存者更有可能报告乳腺癌和宫颈癌筛查,与自体移植幸存者相比,异基因移植幸存者更有可能报告在过去一年中进行了皮肤检查。尽管 HCT 幸存者与健康护理提供者的接触程度更高,但他们的健康行为与匹配对照者相似,与未接受 HCT 的癌症幸存者报告的健康行为相当。仍有很大的改进空间。这些发现支持需要进一步教育 HCT 幸存者和卫生保健从业者。